Scottish Patient Safety Programme

Slides:



Advertisements
Similar presentations
Community Pharmacy – Call to Action Derbyshire / Nottinghamshire Area Team.
Advertisements

Improving Care for Older People in Acute Care Penny Bond Implementation and Improvement Team Leader Healthcare Improvement Scotland.
National Standards for Safer Better Healthcare
Scottish Patient Safety Programme – Paediatric Update Jane Murkin, National Co-ordinator, Scottish Patient Safety Programme Julie Adams, National Facilitator,
Respond, Deliver & Enable Membership development report Annual Members’ Meeting 17 September 2008 Margaret Green Deputy Chairman Council of Governors Pauline.
SPSP Medicines Paediatric Networking Event Prepared by: David Maxwell.
Medicines Reconciliation A Whole System Approach Arlene Coulson Principal Clinical Pharmacist, Specialist Services Gordon Thomson Principal Clinical Pharmacist,
Support for Medicines Optimisation. Medicines Optimisation Importance of Medicines Optimisation Potential benefits of optimising medicines Existing investments.
Alan Bigham Programme Manager (Volunteering) Scottish Health Council Feedback on the needs analysis survey.
FORENSIC MENTAL HEALTH SERVICES MANAGED CARE NETWORK An introduction
National data opt-out - Implementation approach
Tracy Ellis Programme Delivery Lead
The collaborative approach was structured in three phases:
Patient Perceptions of Provision of High–Risk Medicines Education in the Community Pharmacy Setting Claire Fernie, Patient Representative1; Alec Murray,
Proctor’s Implementation Outcomes
HEE Nursing Associate Programme
Development and Pilot of the
Improving Care For Older People in Acute Care
Student Quality Ambassador Programme
The Development of a Vocational Training (VT) Foundation Programme for Community Pharmacists Heather Harrison1; Fiona McMillan1; Ailsa Power1; Harry.
Mini-collaborative Medicines management/dementia care
Poster 1. Leadership Development Programme : Leading Cultures of Research and Innovation in Clinical Teams Background The NHS Constitution is explicit.
ii Breast Cancer Care and Community Pharmacy Scotland Project
Chair’s introduction.
A Work-Based Approach to Acute Oncology Education
Results of a focus group and questionnaire.
Nottinghamshire & Derbyshire GP / Pharmacy Transformation Programme Unlocking the Potential of Community Pharmacy Cathy Quinn Pharmacist Lead Newark &
Integration of Primary and Secondary Care Cardiology
Integrating Clinical Pharmacy into a wider health economy
Changes to the Community Pharmacy Contractual Framework in Wales
Introducing 1000 Lives Plus
CCBT TEC.
Powys teaching Health Board
Preventing VTE in hospitalised patients
Grampian COPD MCN Delivering Spirometry in a Community Pharmacy setting, a rural solution? Small I (1,2), Clelland J (1,2), Robertson W (1), Freeman D.
What barriers and facilitators influence the implementation of new high-risk medicine services in Scottish community pharmacies? Ms Natalie Weir1, Dr Rosemary.
Improving Care for Older People in Acute Care
Testing and improving the tools in daily practice……
Developing a Patient Safety Programme for Primary Care
Transforming Maternity Services Mini-Collaborative
Gary Jenkins Director, Regional Services 27 September 2016
Improving Care for Older People in Acute Care
Derek Feeley Director General and Chief Executive, NHSScotland.
for the Surrey Heartlands CCGs
Victoria Gemmell1 Professor Alex Mullen2
  Scottish Patient Safety Programme in Primary Care (SPSP – PC) Implementation & Spread Strategy 2013–2018.
Analysis of the Reporting and Classification
Reducing The Stigma in Mental Health – An Evaluation of a Joint Acute and Mental Health Trust Shared Learning Programme Anthony Young1 Lead Pharmacist.
Housekeeping The is no fire alarm test planned for today
25th November 2010 Presenter: Sara Jones Clinical Director Welsh Ambulance Services NHS Trust.
  Implementing the Scottish Patient Safety Programme in Primary Care (SPSP – PC)
FORENSIC MENTAL HEALTH SERVICES MANAGED CARE NETWORK An introduction
Implementing the Scottish Patient Safety Programme in Primary Care
Shifting the Focus Supporting Quality Improvement Community Health Partnerships and Community & Primary Healthcare Services Martin Moffat Shifting.
Tuesday 11 May 2010 Insert name of presentation on Master Slide.
Medicines Safety Programme
Welcome. Supporting Realistic Medicine through the delivery of a Single National Formulary.
Programme Board meeting
Author: Beke Tshuma Implementation Lead – Older Person’s Care
Community Dispensing of Oral Medication for Prostate Cancer Patients
Moving Forward Together Programme Overview
Introducing 1000 Lives Plus
Claire Vaughan- Head of Medicines Optimisation, Salford CCG
Transforming Maternity Services Mini-Collaborative
Changes to the Community Pharmacy Contractual Framework in Wales
What next ? This session is about supporting delegates to go back to their practice and implement the programme.
By: Andi Indahwaty Sidin A Critical Review of The Role of Clinical Governance in Health Care and its Potential Application in Indonesia.
Clinical Governance Support Unit
Community pharmacy and Primary Care Networks – what you need to know This presentation provides a brief summary on Primary Care Networks (PCNs) and the.
Presentation transcript:

Scottish Patient Safety Programme Pharmacy in Primary Care, Pilot Project: Warfarin Bundle INTRODUCTION The Scottish Patient Safety Programme (SPSP) in conjunction with Healthcare Improvement Scotland (HIS) initiated a pilot project for Pharmacy in Primary Care (SPSP-PPC) This would run for approximately 2 years; July 2014 – September 2016. The aim of the project was to reduce the number of events which cause avoidable harm from healthcare delivered in any primary care setting through: Improving medicines safety in primary care Raising awareness of safety culture in community pharmacy Enhancing communication between pharmacists, GP’s and the acute hospital setting The pilot project focus being: Year 1 – high risk medicines and safety climate, working within pharmacy teams Year 2 – medicines reconciliation involving joint working between pharmacy, GP’s and the acute hospital setting using the electronic Immediate Discharge letter NHS Grampian (NHSG) was one of only four boards recruited to participate in the pilot along with NHS Highland, NHS Fife and NHS Greater Glasgow & Clyde. Community pharmacy teams All community pharmacists in NHSG were invited to apply to participate in the pilot and five teams were selected. The pharmacies ranged in size and are a mixture of independent and multiples. Enthusiastic members from each of the pharmacy teams attended the National Launch Event in Edinburgh in November 2014, a further National Learning and Sharing Event in November 2015 and 2 Local Learning Events, March 2015 and June 2016. High Risk Medicines Year 1 of the pilot focused on high risk medicines. NHSG chose warfarin which also linked well with work that General Practices across Grampian continued to undertake at the time. The pharmacy teams collected data on all of their Warfarin patients (314 in total for 5 teams) so our data is cumulative. Since September 2015 we have been collecting data on 5 random patients/ monthly to ensure reliability is built into day to day practice. Evaluation A formal evaluation has been undertaken on behalf of HIS by the University of Strathclyde. Informal feedback from the pharmacy teams has been very positive, patients are reportedly delighted to have the opportunity to discuss their warfarin management and care. It has also been noted that some patients are now engaging more with the community pharmacy teams around other medication issues. PROGRESS TO DATE Next Steps Over the next few months the pharmacy teams along with the Clinical Lead will be supporting other Community Pharmacy teams to undertake improvement work around Warfarin and encouraging their participation in the Safety Climate Survey. Local and National “Road Shows” and learning events are planned to allow information sharing and collaborative learning. The teams themselves have already been planning how to spread the bundle approach so they can look at other high risk medicines such as Lithium, Methotrexate and Insulin. Further national development of a combined Non Steroidal Anti Inflammatory Drug (NSAID) bundle will be tested within the origonal 5 teams in NHSG over the next 6 – 9 months. Key Contacts Mark Easton, Pharmacist Clinical Lead e-mail: mark.easton2@nhs.net Tel: 01343 830249 @harrysgranda Louise C Black, Quality Improvement Facilitator, Patient Safety e-mail: louise.black@nhs.net Tel: 01343 567176 @louise_64spsp